We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
-1.48%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$8.62B
AUM Growth
+$909M
Cap. Flow
+$1.08B
Cap. Flow %
12.54%
Top 10 Hldgs %
46.51%
Holding
4,415
New
496
Increased
1,592
Reduced
940
Closed
278

Sector Composition

Rank Sector Weight
1 Energy 7.66%
2 Financials 4.76%
3 Technology 3.4%
4 Industrials 2.32%
5 Communication Services 2.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IO
2801
DELISTED
ION Geophysical Corporation
IO
$13K ﹤0.01%
307
-260
-46% -$13.9K
GAME
2802
DELISTED
SHANDA GAMES LTD SPON ADR REPSTG CL A (CAYMAN ISLANDS)
GAME
$13K ﹤0.01%
+2,000
New +$13K
TZO
2803
DELISTED
ISHARES S&P TARGET DATE 2035 ETF
TZO
$13K ﹤0.01%
+290
New +$12.8K
APAGF
2804
DELISTED
APCO OIL AND GAS INTERNATIONAL INC
APAGF
$13K ﹤0.01%
+1,000
New +$13K
HBANP
2805
DELISTED
Huntington Bancshars Inc. Pfd Ser A
HBANP
$13K ﹤0.01%
10
-150
-94% -$200K
CBB
2806
DELISTED
Cincinnati Bell Inc.
CBB
$13K ﹤0.01%
752
-508
-40% -$9.56K
AXJL
2807
DELISTED
WisdomTree Asia-Pacific ex-Japan Fund
AXJL
$13K ﹤0.01%
190
-651
-77% -$46.1K
EIV
2808
DELISTED
Eaton Vance Municipal Bond Fund II
EIV
$13K ﹤0.01%
1,011
+4
+0.4% +$50
CZR
2809
DELISTED
Caesars Entertainment Corporation
CZR
$13K ﹤0.01%
1,000
ABUS icon
2810
Arbutus Biopharma
ABUS
$873M
$12K ﹤0.01%
+550
New +$8.98K
ATHE
2811
Alterity Therapeutics
ATHE
$82.3M
$12K ﹤0.01%
+92
New +$12.3K
DTD icon
2812
WisdomTree US Total Dividend Fund
DTD
$1.65B
$12K ﹤0.01%
+334
New +$12K
EWN icon
2813
iShares MSCI Netherlands ETF
EWN
$570M
$12K ﹤0.01%
500
-14
-3% -$343
EWT icon
2814
iShares MSCI Taiwan ETF
EWT
$10.1B
$12K ﹤0.01%
386
-114
-23% -$3.66K
FHLC icon
2815
Fidelity MSCI Health Care Index ETF
FHLC
$3.29B
$12K ﹤0.01%
397
FR icon
2816
First Industrial Realty Trust
FR
$8.87B
$12K ﹤0.01%
700
GE icon
2817
CALL
GE Aerospace
GE
$376B
$12K ﹤0.01%
2,107
+20
+1% +$2.49K
HLF icon
2818
Herbalife
HLF
$1.26B
$12K ﹤0.01%
550
-2,020
-79% -$54K
KNDI
2819
Kandi Technologies Group
KNDI
$64.3M
$12K ﹤0.01%
920
LSTA icon
2820
Lisata Therapeutics
LSTA
$14.2M
$12K ﹤0.01%
15
MSGS icon
2821
Madison Square Garden
MSGS
$9.61B
$12K ﹤0.01%
244
+202
+481% +$9.11K
PBW icon
2822
Invesco WilderHill Clean Energy ETF
PBW
$408M
$12K ﹤0.01%
364
SIG icon
2823
Signet Jewelers
SIG
$3.67B
$12K ﹤0.01%
102
+59
+137% +$6.52K
SLAB icon
2824
Silicon Laboratories
SLAB
$7.18B
$12K ﹤0.01%
300
-252
-46% -$11.1K
SMCI icon
2825
Super Micro Computer
SMCI
$19.6B
$12K ﹤0.01%
+4,000
New +$10.4K

Similar funds

Creative Planning's Q3 2014 Portfolio in Review

As of Q3 2014, Creative Planning held 4,415 positions worth $8.62B, up 12% from $7.71B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Creative Planning deployed $1.08B of net new capital in Q3 2014, opening 496 new positions and adding to 1,592 existing holdings. Its largest new stake was Weatherford International plc: 67,854 shares worth $1.41M.

By sector, the portfolio is most concentrated in Energy at 7.7% of assets, down from 7.7% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $260M trimmed.

  • Creative Planning's largest Q3 2014 buy was Weatherford International plc: 67,854 shares worth $1.41M.
  • Creative Planning added most to iShares Core US Aggregate Bond ETF in Q3 2014, an estimated $363M increase.
  • Creative Planning's biggest Q3 2014 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $260M.
  • Creative Planning fully exited EQUAL ENERGY LTD COM in Q3 2014, selling an estimated $2.76M.
  • Creative Planning's ten largest holdings make up 47% of its $8.62B portfolio in Q3 2014.
  • Creative Planning opened 496 new positions and closed 278 in Q3 2014.
  • Creative Planning's portfolio value rose 12% quarter-over-quarter to $8.62B.

Based on Creative Planning's 13F filing for Q3 2014, filed 10 Oct 2014.